(Q41034813)

English

Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine

scientific article published on March 1998

In more languages
default for all languages
No label defined

No description defined

Statements

Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine (English)
0 references
Audrey Clary
0 references
Annick Larrue
0 references
Philippe Pourquier
0 references
1 March 1998
March 1998
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit